Your browser doesn't support javascript.
loading
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway.
Trinh, Nhung Th; Jödicke, Annika M; Català, Martí; Mercadé-Besora, Núria; Hayati, Saeed; Lupattelli, Angela; Prieto-Alhambra, Daniel; Nordeng, Hedvig Me.
Afiliación
  • Trinh NT; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway. Electronic address: nhung.trinh@farmasi.uio.no.
  • Jödicke AM; Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.
  • Català M; Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.
  • Mercadé-Besora N; Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.
  • Hayati S; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
  • Lupattelli A; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
  • Prieto-Alhambra D; Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK; Department of Medical Informatics, Erasmus Medical Center, Rotterdam, Netherlands.
  • Nordeng HM; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.
Lancet Respir Med ; 12(5): e33-e34, 2024 May.
Article en En | MEDLINE | ID: mdl-38614106

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2024 Tipo del documento: Article